ASAP Act

Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.

SCR CollinsSponsor

59 cosponsors · 33 D, 25 R, 1 I

SCR Capito CCD Cortez Masto MWD Warner JBR Banks JLR Lankford TDD Duckworth JKR Kennedy CBD Booker JMR Moran SDR Daines TTR Tillis DFR Fischer LMR Murkowski RSR Scott KCR Cramer CHR Hyde-Smith MRR Rounds KBR Britt AKD Klobuchar CCD Coons KGD Gillibrand AAR Armstrong MKD Kelly RWR Wicker JHR Hoeven MHD Hirono MCD Cantwell JSD Shaheen TSD Smith CVD Van Hollen AKD Kim JRD Reed ESD Slotkin LBD Blunt Rochester RGD Gallego JRR Risch PWD Welch APD Padilla MHD Heinrich DMR McCormick GPD Peters MBD Bennet MHD Hassan JBR Boozman JJR Justice TTR Tuberville BLD Luján SWD Whitehouse RBD Blumenthal JCR Cornyn JHD Hickenlooper JFD Fetterman JRD Rosen TYR Young BCR Cassidy TBD Baldwin ASD Schiff AKI King PMD Murray

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.